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The COVID-19 pandemic has motivated countries around the world to obtain high-resolution data on the local spread of SARS-CoV-2 and arising variants of interest and variants of 
concern (VOCs). Worldwide, more than 2 million strains have been 
sequenced and genome information has been made available at 
GISAID. Within the first 100 days of the emergence of SARS-CoV-2, 
genomic analyses from various countries led to the development of 
vaccines that have now reached the market. Genomic surveillance of 
SARS-CoV-2 is commonplace in high-income countries but is also 
highly necessary in low- and middle-income countries (LMICs), 
including Bangladesh, to guide within-country health policies per-
tinent to the pandemic.
In an unprecedented global response to the COVID-19 pan-
demic, many countries, including Bangladesh, acted rapidly to 
restrict population movement and introduce additional social and 
behavioural interventions to slow the spread of the virus. Until 
now, the impact of these policies has been hard to assess, in part 
because of the near-universal difficulties that countries have had 
rapidly scaling up PCR with reverse transcription (RT–PCR) test-
ing capacity. Bangladesh is a LMIC with a population of more than 
166 million people, 63% of whom live in rural regions1,2. The first 
confirmed case of SARS-CoV-2 in Bangladesh was reported on 8 
March 2020 by the Institute of Epidemiology Disease Control and 
Research (IEDCR). To reduce community transmission during the 
first wave, the Government of Bangladesh announced an official 
National General Holiday on 23 March effective from 26 March to 4 
April, which was thereafter incrementally extended until 30 May. As 
of 12 July 2021, there were >1 million confirmed COVID-19 cases 
(case fatality rate, 1.61%)3. Although testing capacity was rapidly 
expanded, training and infrastructure for accurate epidemiological 
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surveillance, particularly outside the capital Dhaka, remained 
challenging. As a result, it has been unclear how the epidemic has 
spread in Bangladesh and what this means for the potential spread 
of SARS-CoV-2 variants, and the best use of interventions, includ-
ing therapeutics and vaccines.
Viral genomics analyses have been used to track the SARS-CoV-2 
epidemic, enabling fine-scaled transmission mapping and analy-
sis of how changes in population behaviour impact patterns of 
transmission4. For example, genomics analysis has been used to 
disentangle the timeline of spread in Europe5 and to understand 
community transmission versus international importations in New 
Zealand6. Despite sequencing of >2,000 SARS-CoV-2 genomes 
from Bangladesh, only a handful of studies report the phylogenetic 
placement of those strains7–10.These phylogenetic approaches pro-
vide a window into the biology of transmission that is independent 
of the capacity of the health system to detect cases. Similarly, mobile 
phone data have been used extensively as a way to monitor the pop-
ulation behavioural response to the epidemic in real time, and to 
understand the human drivers of transmission11,12. These new data 
streams may be particularly powerful tools for monitoring the pan-
demic in LMICs, in which RT–PCR testing capacity is often highly 
constrained.
Worldwide genomic surveillance has been rapidly scaled up in 
response to the emergence of VOCs in late 2020. Pango lineages4 
B.1.1.7, B.1.351, P.1 and B.1.617.2 have been designated as VOCs on 
the basis of their observed heightened risk in terms of transmissibil-
ity, severity, vaccine or immune evasion, and have been renamed 
Alpha, Beta, Gamma and Delta, respectively. It is essential that these 
variants and any newly emerging variants are observed and moni-
tored by genomic surveillance in LMICs as well as in high-income 
countries (HICs). This is partly enabled through international data 
sharing on global databases such as GISAID.
To inform health policies for SARS-CoV-2 control at the national 
level, we combined viral genomics and population mobility data to 
analyse the emergence and outbreak trajectory of SARS-CoV-2 in 
Bangladesh.
Results
SARS-CoV-2 lineages in Bangladesh between March and 
July 2020. SARS-CoV-2-positive samples were collected by the 
IEDCR from patients in six administrative areas between March 
and July 2020 (Supplementary Table 1). Samples were tested for 
SARS-CoV-2 using RT–PCR and 67 positive samples were trans-
ferred to the Institute for Developing Science and Health Initiatives 
for sequencing. We combined our data with 324 publicly avail-
able genomes from Bangladesh that were sampled during the first 
wave (Supplementary Table 2, acknowledged in the Supplementary 
Information) and added 68,870 international genomes from 
GISAID for phylogeographical context (Fig. 1a).
The 391 isolates from Bangladesh fell into 19 lineages, assigned 
by the Pangolin lineage software4 (Pango lineages A, A.9, B, B.1, 
B.1.1, B.1.1.1, B.1.1.25, B.1.1.25.2, B.1.1.59, B.1.1.60, B.1.148, 
B.1.159, B.1.2, B.1.36, B.1.5, B.1.5.12, B.1.79, B.1.93 and B.2.1). Of 
the 19 lineages, 85% of isolates fell into the three dominant lineages 
all possessing single-nucleotide variants A23403G, C14408T and 
C3037T. The list of amino acid substitutions, insertions or dele-
tions is provided separately in Supplementary Table 3. Bayesian 
phylodynamic analysis estimated that the mutation rate of the iso-
lates from Bangladesh is 0.7 × 10−3 substitutions per site per year 
(~20 mutations per genome per year), which is consistent with 
global estimates5. Phylodynamic analysis of the most recent com-
mon ancestor (MRCA) predicted that SARS-CoV-2 first appeared 
in mid-February 2020 in Bangladesh (Fig. 1b), consistent with 
other global estimates5. The first positive case was detected in early 
March, within two weeks of the predicted first introduction.
Population dynamics of SARS-CoV-2 in Bangladesh in 2020. On 
the basis of an analysis of the 391 sequences from Bangladesh that 
were sampled during the first wave, it is apparent that Pango lineage 
B.1 was the first SARS-CoV-2 lineage to be observed in Bangladesh, 
and had infected a traveller returning from Italy on 7 March. While 
B.1 predominated until the end of March, multiple other minor 











































Fig. 1 | Phylogenetic analysis of 391 Bangladesh SARS-CoV-2 genomes March–July 2020. a, Maximum-likelihood phylogenetic analysis of 391 viruses 
sampled from Bangladesh (black) on a background of 68,870 publicly available GISAID global sequences in collapsed clades. Collapsed clades are coloured 
by the predominant region/country that they were sampled in (blue, Europe; red, United States; green, India; pink, Middle East). International arrival 
frequencies from those regions between 18 February 2020 and 18 March 2020 are displayed in a bar chart and shown in the same colours. b, Maximum- 
likelihood Bayesian time-scaled phylogenetic analysis generated using BEAST (v.1.10.4); clades, internal nodes and migration events are annotated.
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Fig. 2 | Lineage dynamics of 391 Bangladesh SARS-CoV-2 genomes March–July 2020. a, Proportional bar plot of Pango lineage diversity in Bangladesh 
between March and July 2020. b, Steam graph of the lineage dynamics between March and July 2020. c, Bubble plot of the representation of Pango 
lineages across eight divisions of Bangladesh.
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B.1.79) during March but failed to disseminate widely. After March, 
three lineages dominated—lineages B.1.1 and B.1.1.25 (first detected 
5 April 2020 and 8 April 2020, respectively) and lineage B.1.36 (first 
detected at the end of March) (Fig. 2). None of these lineages shared 
an MRCA with other lineages present only in Bangladesh, rather, 
they were all derived from lineages that were established and cir-
culating outside Bangladesh and that therefore represent separate 
introductions from the global outbreak pool (Fig. 1). B.1.1.25 has 
also been detected in the United Kingdom and Australia. Our data 
suggest that lineage B.1.1.25 was imported into Bangladesh at least 
twice before the cessation of international air travel on 21 March 
(Fig. 1a,b). B.1.1 seems to have been imported into Bangladesh at 
least five times, from both the United States and Europe (Fig. 1a). 
In contrast to lineages B.1.1 and B.1.1.25, phylogenetic analysis of 
lineage B.1.36 indicates that there was a single importation event 
linked to a traveller returning from Saudi Arabia who tested positive 
on 22 March in the Chattogram Division.
All three dominant lineages expanded clonally through sus-
tained community transmission after the end of March (Fig. 2) to 
comprise 19% (B.1.1), 58% (B.1.1.25) and 8% (B.1.36) of all sam-
ples sequenced after this time. Lineages B.1.1 and B.1.1.25 were 
found dispersed throughout most divisions of Bangladesh (Fig. 2c). 
Lineage B.1.36 predominated in southern Bangladesh; 64% of iso-
lates were found in the Chattogram Division. The remaining B.1.36 
samples were found in Dhaka, Barisal, Khulna, Rajshahi, Rangpur 
and Sylhet, but only in small numbers (observed in up to two sam-
ples at each listed location).
Lineage A, which was present at the beginning of the pandemic 
in China in 2019 before the introduction into Europe in 2020, 
was not detected in Bangladesh until April 2020 (Fig. 1b), did not 
expand or disseminate widely, and may have been introduced by 
widespread dispersal in India before being detected in Bangladesh 
(Fig. 1a).
Mass migration in Bangladesh at the end of March 2020. Mobility 
data from Facebook users were available from 22 March, and from 
mobile phone operators from 27 April. An analysis of the mobil-
ity patterns among approximately 6,600 Facebook users (Fig. 3a) 
shows that around 14.2% of users left Dhaka between 23 and 26 
March, indicating a mass migration out of Dhaka to all areas of 
the country. The displacement of individuals from the city to other 
parts of the country is illustrated by the increase in the population 
relative to the baseline in rural areas such as Barisal. Note the large 
spike of movement associated with the evacuation of Barisal due 
to Cyclone Amphan in May13. Interestingly, from Fig. 3a, in areas 
such as Gazipur and Narayanganj, it is apparent that, after initial 
displacement, people returned in late April14; our data show that this 
was followed by a return to Dhaka in late May (Fig. 3a).
Figure 3b illustrates the distribution of journey lengths, which are 
a proxy for movement patterns, taken by approximately 100 million 
mobile phone subscribers from three of four Bangladeshi operators 
from May to August. The impact of Eid—a national holiday during 
which many people travel to visit family and friends—is visible in 
July, with more long-distance trips occurring compared with other 
months. The percentage of long-distance trips (>50 km) travelled 
during the month of Eid (July) was significantly different compared 
with that of other months—the percentage of long-distance trips in 
July was 71.1% (95% confidence interval (CI) = 71.0–71.2%); the 
percentage of long-distance trips in August, the next highest month, 
was 57.9% (95% CI = 57.9–58.0%). In general, the distances travelled 
are considerable due to the country’s geography (Bangladesh spans 
600 km east to west) and are consistent with Bangladesh’s highly 
mobile populations. Figure 3c shows the large number of subscrib-
ers travelling to and from Narayanganj, one of the first hotspots of 
SARS-CoV-2 and a continuing driver of transmission, throughout 
the summer. Together, these mobility data are consistent with the 
rapid dissemination of SARS-CoV-2 out of Dhaka to the rest of the 
country, as people left the city at the end of March, and frequent 
travel around Bangladesh sustaining transmission subsequently.
Mass migration was the main driver of countrywide spread 
in 2020. Combining two data streams (population mobility and 
genomics data) revealed a link between the expansion of three dom-
inant lineages and the mass migration that occurred at the end of 
March at the beginning of the general holiday. This is evidenced by 
the maximum clade credibility tree in Fig. 1b that dates the MRCA 
for all three dominant lineages directly before the observed mass 
migration when the mobility data usage swapped from cities to 
regional towns (Fig. 3). The resulting expansion of lineages B.1.1, 
B.1.1.25 and B.1.36 is shown in Fig. 2, which shows that these domi-
nant lineages outcompeted other lineages, and reveals the rapid dis-
semination of these lineages to most areas of the country after the 
mass migration event at the end of March 2020.
Given the daily migration of the Bangladeshi population into 
and out of major cities, the risk for sustained transmission and 
expansion of SARS-CoV-2 remains extremely high and limits the 
effectiveness of behavioural interventions. This highly mobile 
population seems to have rapidly transported lineages across the 
country. This occurred mainly when workers living and working 
in cities returned home to rural areas because schools, offices and 
other working places closed.
Genomic surveillance reveals Beta VOC dominance in 2021. 
To establish whether there had been recent changes in lineage 
dynamics or international importations, we sequenced a further 85 
SARS-CoV-2 samples (Supplementary Table 4) in April 2021 that 
were sampled between November 2020 and April 2021. Of these 
85 sequences, 30 were lineage B.1.1.25 (35%), 13 were VOC Alpha 
(B.1.1.7; 15%), 40 were VOC Beta (B.1.351; 47%), 1 was lineage 
B.1.1.315 and 1 was lineage B.1.525.
To investigate the emergence of lineages of concern Alpha 
(B.1.1.7) and Beta (B.1.351) in Bangladesh, a Nextstrain phyloge-
netic tree was built (Fig. 4). This revealed continuous transmis-
sion of lineage B.1.1.25 from the first wave and showed that B.1.1 
and B.1.36 had been eliminated. Multiple introductions of Alpha 
B.1.1.7 occurred in Bangladesh after December 2020, but most 
were not established. More recently, in February 2021, a transmis-
sion chain became established in the community that resulted in 
non-travel-associated cases. Most concerning is the recent domi-
nance of Beta (B.1.351), which has been assigned to a large number 
of cases that were not associated with travel and is responsible for 
47% of our randomly sampled and recently sequenced cases. More 
than 85% of our Beta (B.1.351) sequences were sampled in Dhaka. 
Several other researchers who are sequencing viruses sampled in 
Bangladesh have deposited Beta (B.1.351) lineage sequences in 
GISAID (384 as of July 2021), indicating a lineage expansion and 
confirming that the dominance in our random sample is not a result 
of sampling bias. Further surveillance is necessary to investigate 
how this imported lineage has established and dominated the epi-
demic in Bangladesh so rapidly and what effect this lineage is hav-
ing on transmissibility, mortality and immunity there.
Discussion
In 2020, we sequenced 67 viral genomes from six administrative 
areas (divisions) of Bangladesh using a nanopore MinION device 
and combined these sequencing data with already-deposited 
global SARS-CoV-2 genomes (including 324 from Bangladesh 
COVID-19 cases) to show how early repeated international intro-
ductions into Bangladesh were replaced by endemic spread of 
three dominant lineages that dispersed the country in late March. 
Population mobility patterns analysed from digital trace and mobile 
phone data showed that the switch in the dynamics of SARS-CoV-2 
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genomic epidemiology coincided with migration out of cities to the 
rest of the country. In 2021, we again used nanopore sequencing 
to provide complete genome sequences of an additional 85 sam-
ples that were isolated between November 2020 and April 2021. 
The 2021 results revealed the presence of VOC Beta (B.1.351) in 
Bangladesh and its dominance in Dhaka, the capital of Bangladesh.
Our analyses of the genomic epidemiology of SARS-CoV-2 and 
population mobility in Bangladesh during the first wave of 2020 
indicate that repeated international importations until late March 
were followed by a period of sustained community transmission 
that was consistent with a mass exodus from urban areas. A ban on 
international and domestic flights (21 March 2020) was probably 
the end point of international importations and 23 March marked 
the beginning of the expansion and dispersal of three dominant lin-
eages in Bangladesh. The predicted introduction of SARS-CoV-2 
into Bangladesh during mid-February is consistent with other 
global estimates that predicted that lineage B.1 was imported into 
Italy in late January but not detected until mid-February4,5.
Recent studies have linked a ~50 kb genomic locus inherited by 
modern humans from Neanderthals to a heightened risk of severe 
disease from COVID-19 (refs. 15,16). Importantly, the highest car-
rier frequency of this high-risk haplotype is found in Bangladesh, 
underlining the need for the continued strengthening of exist-
ing surveillance, monitoring systems and interventions to reduce 
transmission. To date, published studies reporting the effect of 
non-pharmaceutical interventions on lineage diversity have focused 
on HIC settings17. Although only a few studies have investigated 
the intricacies and specificities of differences in the dissemination 
of SARS-CoV-2 in low-income settings, those that have revealed 
that transmission dynamics can be completely different from 
HIC settings18.
Evidence from our study has revealed that stay-at-home orders 
can exacerbate transmission in LMICs with similar demographic 
specificities to Bangladesh by inducing mass migrations out of cities 
and return of transient workers to rural villages once work oppor-
tunities shut. Our finding, that non-pharmaceutical interventions 
(such as stay at home orders) that have been successful in HIC set-
tings can’t always be applied identically in LMICs, is important and 
will continue to be relevant in light of the emergence and domi-
nance of VOCs.
It is important to note that the Oxford–AstraZeneca vaccine was 
rolled out in Bangladesh from February 2021. The recent evidence 
of reduced efficacy of this vaccine against Beta (B.1.351) and Delta 
(B.1.617.2)19 further underscores the need for accurate and timely 
monitoring of VOCs. Moreover, the recent submission of other 
VOCs, including the Gamma variant (P.1) (February 2021) and 
Delta variant (B.1.617.2) (May 2021) in GISAID from Bangladesh 
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Fig. 3 | Population mobility dynamics in Bangladesh 2020. a, The percentage change in the Facebook user population over time for each district in 
Bangladesh (grey lines) compared with a baseline average. Specific districts are highlighted; the Dhaka district is shown in red. The dashed vertical lines 
indicate notable events. b, The distribution of trips from Dhaka by distance (km) travelled for each month and during Eid (29–31 July) based on call detail 
records data from three mobile phone operators. c, The number of subscribers travelling to and from Narayanganj.
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and reduce the possibility of countrywide spread. Our study exem-
plifies the advantages of combining mobility and genomic data to 
untangle outbreak dynamics to shape policies and interventions as 
the outbreak spreads. Here we provide evidence that policies that 
limit intracountry travel could reduce the incidence of VOCs in 
more rural areas of Bangladesh and should be swiftly implemented 
to prevent a rapid rise in cases outside of Dhaka.
Throughout the Bangladesh epidemic, our genomic epidemi-
ology consortium has been in constant contact with key policy 
makers in Bangladesh. Since March 2020, we have been actively 
collaborating with national and international institutes on 
SARS-CoV-2 genomics and have provided genomic information to 
the Directorate General of Health Services (DGHS) and Ministry of 
Health and Family Welfare (MoFHW), Bangladesh. This has led to 
important policy decisions in response to the detection of the Alpha 
variant in early 2021 and Beta variant a few months later. For exam-
ple, the government immediately quarantined patients who were 
positive for the SARS-CoV-2 Alpha variant (B.1.1.7), including 
travellers and their contacts, and enforced mandatory institutional 
quarantine for 14 days from 29 December 2020, for any incoming 
passengers from high-risk countries to Bangladesh.
Then, a few months later, when the Beta variant (B.1.351) 
emerged in Bangladesh, the government immediately quarantined 
infected individuals and their contacts, imposed restrictions on 
intercity movement and successfully limited the transmission across 
Bangladesh.
Moreover, in an important differentiation from interventions that 
were in place during the first wave, the government of Bangladesh 
also imposed a restriction on intercity movement (beginning June 
2021) to prevent mass migration disseminating SARS-CoV-2 and 
VOCs across Bangladesh.
The global incidence of VOCs has continued to rise linearly 
throughout 2021, and lessons learnt during initial waves in 2020 
(such as spread through mass migration) must be applied to stem 
the curve of the ongoing pandemic and increasingly transmis-
sible variants20. Our study shows what can be achieved locally as a 
result of international collaboration using continuous genomic sur-
veillance. Our consortium is committed to continuing to provide 
information on SARS-CoV-2 as the situation develops to give the 
required support to the Government of Bangladesh as well as to any 
other similar country settings.
We hope that our findings on outbreak dynamics in Bangladesh 
will help countries with similar healthcare challenges to develop 
research capabilities to monitor outbreaks and inform national 
social and healthcare policies to suppress the transmission of 
SARS-CoV-2.
Methods
Sample collection. As of 12 July 2021, the total number of COVID-19 testing 
facilities across Bangladesh was 613 (ref. 3). IEDCR was the first institute in the 
country to start testing for SARS-CoV-2 using RT–PCR. Thus, samples received 
at the IEDCR were available for sequencing from the start of the outbreak. In 
2020, we sequenced 67 SARS-CoV-2-positive samples from between 8 March and 
5 July. Furthermore, for our analysis, we included 324 SARS-CoV-2 strains from 
Bangladesh and 68,870 global SARS-CoV-2 sequences that had been deposited at 
the GISAID as of 31 July 2020, acknowledged in the Supplementary Information. 
In 2021, we sequenced an additional 85 SARS-CoV-2-positive samples that were 
obtained between 11 November 2020 and 15 April 2021.
Whole-genome sequencing. Patient samples that were positive for SARS-CoV-2 
on the basis of RT–PCR analysis were selected for sequencing. Stored 
nasopharyngeal swabs were re-extracted using the QIAamp Viral RNA Mini Kit 
(QIAGEN) and confirmed with RT–PCR using the WHO recommended primers 
and probes targeting the E and N genes. Samples with Ct values of less than 31 were 
retained for further analysis. The initial 67 samples were sequenced according to 
the Arctic nCoV-2019 sequencing protocol v2 (GunIt) (https://www.protocols.
io/view/ncov-2019-sequencing-protocol-v2-bdp7i5rn?version_warning=no), 
while the later 85 samples were sequenced according to the Arctic nCoV-2019 
sequencing protocol v3 (LoCost) (https://www.protocols.io/view/ncov-2019-sequ
encing-protocol-v3-locost-bh42j8ye). In brief, viral cDNA was synthesized 
using either SuperScript IV (Thermo Fisher Scientific) or the LunaScript RT 
SuperMix Kit (New England BioLabs) followed by second-strand synthesis using 
the Q5 high-fidelity DNA polymerase (New England BioLabs). Sequencing 
libraries were then constructed using the Oxford Nanopore ligation sequencing 
kit (SQK-LSK109). Libraries were sequenced using R9.4.1 MinION flow cells. 
Sequenced genomes were recovered by mapping pass quality reads against the 





























Fig. 4 | Bangladesh genomes in the context of a Nextstrain time-scaled global phylogeny. a, Nextstrain time-scaled phylogeny of 1,489 representative 
global sequences of SARS-CoV-2 sampled from GISAID on 20 April 2021. Pango lineages labelled on clades, and Bangladesh sequences (n = 166) are 
highlighted at the tips, coloured by lineage membership. b, Map of Bangladesh with pie chart representations of Pango lineage representation in each locality.
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(ARTIC-nCoV-bioinformaticsSOP-v.1.1.0) pipeline for sequence correction, 
single-nucleotide polymorphism calling and generation of the consensus sequence. 
We used high coverage (200×) to account for random sequencing errors, and 
regions with low coverage or low quality were masked using Ns. Lineages were 
assigned according to the proposed nomenclature of Pangolin lineage assignment 
software v.2.0.7 and lineage version 2020-08-29 (https://github.com/hCoV-2019/
pangolin).
Phylogenetic analysis. SARS-CoV-2 sequences from Bangladesh, deposited at the 
GISAID before 31 July 2020 (n = 391), were phylogenetically placed onto a global 
tree of 68,870 SARS-CoV-2 global sequences available from GISAID (31 July 2020). 
The total available (78,448) was filtered for those with short/ambiguous sequences 
to leave 68,870 sequences. The global tree was provided by R. Lanfear in his  
31 July 2020 update21. The alignment of 68,870 sequences and the global tree was 
used with Llama software v.0.1 to place the 324 Bangladeshi sequenced strains in 
the global phylogenetic context22. Llama parameters, including a selection of five 
lineage representatives and an extraction of six from the larger tree radius, were 
used to investigate the phylogeography of the Bangladesh isolates.
We used TempEst v.1.5.3 to investigate the evolutionary tempo of the 2020 
samples23 (Supplementary Fig. 1). We found a positive correlation with the 
temporal signal and a low to moderate association between genetic distances and 
sampling dates (R2 = 0.2471), reflecting the low mutation rate of SARS-CoV-2, 
which is consistent with findings reported elsewhere. Given the positive 
correlation, we determined that these data were suitable for phylogenetic 
molecular clock analysis in BEAST24. We used a time-aware coalescent Bayesian 
exponential growth model that is available in BEAST (v.1.10.4). The HKY+Γ 
model of nucleotide substitution was used with a strict molecular clock. Parameters 
were estimated using the Bayesian Markov Chain Monte Carlo framework, with 
100,000,000-step-long chains, sampling every 1,000 steps and removing the 
initial 10% as burn-in. Sufficient sampling was assessed using Tracer (v.1.7.1), by 
verifying that every parameter had effective sampling sizes of more than 100. The 
resulting phylogenies were visualized with a maximum clade credibility tree in 
FigTree (v.1.4.4).
To update our phylogenetic analysis with our recent 2021 samples, we 
constructed a Nextstrain25 build using their global subsampling scheme across 
1,045,491 sequences downloaded from GISAID on 20 April 20 2021. We selected 
one representative sequence from each country, year and month from the 
downloaded global sample. This resulted in 1,317 background global strains to 166 
Bangladesh sequences, 152 provided by this study and 14 provided for background 
context and acknowledged in the Supplementary Information.
Mobility analysis. Anonymized and aggregated daily population location data 
of Facebook users in Bangladesh were provided by Facebook Data for Good26. 
These data capture Facebook users who provide location information through the 
Facebook app by having location services enabled. The population of Facebook 
users is determined by the modal location for each individual during every 
eight-hour time window. The data analysed here were aggregated temporally (daily) 
and spatially (districts) and represent the daily count of Facebook users in each 
district from 22 March 2020 onwards. We compared these counts to the average 
number of users in each location during a 45-day baseline period preceding  
22 March. The baseline averages were calculated for each unique day of the week 
and time of day combination. For each district, we calculated the daily percentage 
change in Facebook users compared with the corresponding baseline average.
We derived population mobility estimates from mobile phone call 
detail records provided by three of the four telecommunication operators 
(Grameenphone, Banglalink and Robi Axiata Limited) in Bangladesh. Trips were 
calculated based on changes in a subscriber’s assigned tower location from the 
previous day. All data were aggregated temporally (daily) and spatially (Upazilas; 
sub-district) on the basis of tower locations according to previously described 
methods11,27,28. The aggregated data consist of the daily number of subscribers 
for each Upazila and the total number of trips between all pairs of Upazilas from 
27 April 2020 onwards. Although the Facebook data provide greater temporal 
coverage, they represent a much smaller percentage of the Bangladeshi population. 
The mobile phone data represent around 100 million subscribers across Bangladesh 
and enable us to estimate the daily number of trips each month, including the Eid 
holiday period, at the end of May 2020.
Statistics and reproducibility. No statistical method was used to predetermine 
sample size and no data were excluded from the analyses unless Ct > 31.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
All sequencing data used in this study are available on GISAID, as described 
in the Supplementary Information and in the GISAID acknowledgements 
(Supplementary Data 1). Sequencing reads generated in this study have been 
made available on the NCBI Sequence Read Archive service (BioProject ID: 
PRJNA737194).
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